Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	38.60	10.87	7.84
Graham Fair Price	17.57	249904.26	212562.68
PEG	347.81	0.05	0.01
Price/Book	6.62	0.31	0.29
Price/Cash Flow	96.12	22.75	11.60
Prices/Earnings	-17.47	1.76	2.13
Price/Sales	8.78	1.15	1.06
Price/FCF	96.12	22.75	11.60
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	11.98	0.16	0.14
Operating Margin	19.80	0.13	0.10
ROA	14.88	0.03	0.03
ROE	0.03	0.04	29.20
ROIC	0.03	0.02	-5.68
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	3.10	< 0.005	103705.04
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.06	0.21	282.27
EPS QOQ	1.82	0.34	-81.57
FCF QOQ	-0.47	-0.44	7.81
Revenue QOQ	0.08	0.01	-83.33
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	53.58	59.40	10.86
Days Sales Outstanding (DSO)	84.27	83.97	-0.35
Inventory Turnover	1.68	1.52	-9.80
Debt/Capitalization	0.04	0.13	258.16
Quick Ratio	5.07	2.95	-41.81
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	241153.21	249434.55	3.43
Cash	93212.51	132159.04	41.78
Capex	-164.73	-614.04	-272.76
Free Cash Flow	6120.13	3441.54	-43.77
Revenue	67257.74	68187.61	1.38
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	6.21	3.56	-42.79
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.45	2.25	54.99
Naive Interpretation	Member

06 - Financial Health · Bad

Rating